Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 up, people at high risk and those with occupational exposure to COVID-19
- Written by Matthew Woodruff, Instructor of Human Immunology, Emory University

Following the recommendations of its vaccine advisory committee, the Food and Drug Administration gave emergency use authorization to Pfizer-BioNTech’s COVID-19 vaccine booster dose for...